Last reviewed · How we verify
A Phase II Clinical Trial Evaluating the Safety and Efficacy of Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors
The primary goals of hyperthermia combined with chemotherapy/radiotherapy on treatment failure solid tumors are tumor response rate, while secondary goals are rates of acute and late adverse effects, local control rate, distant metastasis rate, progression-free rate and overall survival rate.
Details
| Lead sponsor | Shin Kong Wu Ho-Su Memorial Hospital |
|---|---|
| Phase | Phase 2 |
| Status | WITHDRAWN |
| Start date | 2014-02 |
| Completion | 2017-02 |
Conditions
- Solid Tumors
Interventions
- Radiation
- Hyperthermia
- Cisplatin
- Taxotere
Primary outcomes
- Tumor response rate — 12 weeks
To estimate the tumor response rate (complete response + partial response; CR + PR; according to RECIST criteria version 1.1).
Countries
Taiwan